146 related articles for article (PubMed ID: 16937477)
1. Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C.
Lin TJ; Liao LY; Lin SY; Lin CL; Chang TA
World J Gastroenterol; 2006 Aug; 12(30):4897-901. PubMed ID: 16937477
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection.
Metwally MA; Zein CO; Zein NN
Am J Gastroenterol; 2004 Feb; 99(2):286-91. PubMed ID: 15046219
[TBL] [Abstract][Full Text] [Related]
3. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
[TBL] [Abstract][Full Text] [Related]
4. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
5. Hepatic iron influences responses to combination therapy with peginterferon alfa and ribavirin in chronic hepatitis C.
Lin TJ; Liao LY; Lin CL; Chang TA; Liu SO
Hepatogastroenterology; 2008; 55(85):1412-5. PubMed ID: 18795701
[TBL] [Abstract][Full Text] [Related]
6. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
7. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
8. [Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease].
Moon JH; Park SH; Oh KC; Jung JO; Shin WG; Kim JP; Kim KO; Park CH; Hahn T; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK; Jun SY
Korean J Gastroenterol; 2006 Jun; 47(6):432-9. PubMed ID: 16809950
[TBL] [Abstract][Full Text] [Related]
9. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.
Beinker NK; Voigt MD; Arendse M; Smit J; Stander IA; Kirsch RE
J Hepatol; 1996 Nov; 25(5):633-8. PubMed ID: 8938538
[TBL] [Abstract][Full Text] [Related]
10. Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C.
Won JE; Jeong SH; Chung JI; Lee JH; Hwang SH; Kim JW; Lee SH; Kim N; Park YS; Lee DH; Kim H
Intervirology; 2009; 52(5):239-46. PubMed ID: 19602897
[TBL] [Abstract][Full Text] [Related]
11. Serum hepcidin levels are related to serum markers for iron metabolism and fibrosis stage in patients with chronic hepatitis B: A cross-sectional study.
Çam H; Yılmaz N
Arab J Gastroenterol; 2020 Jun; 21(2):85-90. PubMed ID: 32423859
[TBL] [Abstract][Full Text] [Related]
12. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
Tsochatzis E; Papatheodoridis GV; Koliaraki V; Hadziyannis E; Kafiri G; Manesis EK; Mamalaki A; Archimandritis AJ
J Viral Hepat; 2010 Nov; 17(11):800-6. PubMed ID: 20002304
[TBL] [Abstract][Full Text] [Related]
13. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
[TBL] [Abstract][Full Text] [Related]
14. [A study on hepatic iron overload in chronic hepatitis C patients].
Bomfim EA; Pereirade de Oliveira AC; Paraná R; Schinoni MI
Acta Gastroenterol Latinoam; 2013 Sep; 43(3):212-7. PubMed ID: 24303687
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
16. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis.
Farinati F; Cardin R; De Maria N; Della Libera G; Marafin C; Lecis E; Burra P; Floreani A; Cecchetto A; Naccarato R
J Hepatol; 1995 Apr; 22(4):449-56. PubMed ID: 7545199
[TBL] [Abstract][Full Text] [Related]
17. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.
George DK; Goldwurm S; MacDonald GA; Cowley LL; Walker NI; Ward PJ; Jazwinska EC; Powell LW
Gastroenterology; 1998 Feb; 114(2):311-8. PubMed ID: 9453491
[TBL] [Abstract][Full Text] [Related]
18. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patients.
Batsaikhan B; Gantumur G; Huang CI; Yeh ML; Huang CF; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL; Lee JC; Dai CY
J Chin Med Assoc; 2019 Feb; 82(2):99-104. PubMed ID: 30839498
[TBL] [Abstract][Full Text] [Related]
20. The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients.
Petta S; Grimaudo S; Tripodo C; Cabibi D; Calvaruso M; Di Cristina A; Guarnotta C; Macaluso FS; Minissale MG; Marchesini G; Craxì A
J Clin Endocrinol Metab; 2015 Jan; 100(1):193-200. PubMed ID: 25268393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
